Background: BphB B-356 catalyzes the second step of the PCB catabolic pathway. Result: Apo, binary, intermediate, and ternary structures were obtained. Conclusion: Conformational changes in the substrate binding loop lead to the formation of a structurally defined pocket to catalyze a wide range of substrates. Significance: Recognition of conformational changes in the substrate binding loop and insight into the substrate specificity.
chlorobiphenyl, the product resulting from the metabolism of 2,2Ј,5,5Ј-tetrachlorobiphenyl by BPDO LB400 (13) . To the best of our knowledge, the ability of BphB B-356 to metabolize the product generated from 2,6-dichlorobiphenyl or 2,4,4Ј-trichlorobiphenyl has never been examined. But recently it has been shown that the dihydrodiol dehydrogenase from Sphingomonas sp. strain CHY-1 can oxidize a wide range of polyaromatic hydrocarbon dihydrodiols (14) .
BphB occurs as a homotetramer comprised of 29.4-kDa subunits. It is an NAD ϩ -dependent oxidoreductase, related to other cis-dihydrodiol dehydrogenases involved in aromatic degradation pathways and belongs to a very large family of short-chain dehydrogenase (the SDR family) (15, 16) . Although, the crystal structure of the NAD ϩ -bound form of BphB LB400 is known (17) , there is no structure available with bound substrate, product, or any product analogs. Furthermore, the substrate binding loop in the published structure of BphB LB400 is disordered (17) . Therefore, the structural features involved in substrate binding of the cis-dihydrodiol dehydrogenases from the aromatic degradation pathways are still undetermined.
To get more insight into the binding mode of the ligand with BphB, we have compared the crystal structure of the apo form of BphB B-356 with that of its NAD ϩ -bound form (binary state) or of its ternary complex with its coenzyme-NAD ϩ and its product (2,3-dihydroxybiphenyl) or a product analog (4,4Ј-dihydroxybiphenyl). In addition, we also describe a structure showing an intermediate state of the substrate binding loop. These three-dimensional structures provide insight to the binding mode of ligand with the enzyme. We were able to identify the series of conformational changes in the substrate binding loop that occur during ligand binding. Additionally, our docking studies are consistent with the biochemical experiments that examine the ability of BphB B-356 to metabolize and accommodate a large range of chlorinated substrates.
EXPERIMENTAL PROCEDURES
Preparation of BphB Crystals-Purification, crystallization, and preliminary x-ray diffraction properties of BphB B-356 have been reported earlier (18) . In brief, crystallization conditions for BphB B-356 were screened initially using commercial kits by Hampton Research (Hampton Research Inc., Aliso Viejo, CA). We were able to obtain good diffracting crystals in 0.2 M sodium malonate (pH 6.5) buffer containing 10 -36% (w/v) PEG-3350.
Diffraction data for crystals of substrate-free and NAD ϩ -bound forms of the enzyme were collected on an in-house x-ray setup. Before data collection, the protein crystals were cryoprotected by direct transfer to the mother liquor drop containing 10% (v/v) ethylene glycol as a cryoprotectant. Crystals of the BphB B-356 -NAD ϩ complex were prepared by soaking protein crystals for 15 min at room temperature in a solution comprised of 22% (w/v) PEG-3350, 0.2 M sodium malonate, and 10 mM NAD ϩ . Diffraction data were collected under cryogenic conditions (ϳ100 K).
Protein crystals were also soaked (for 50 s to 15 min) with 2,3-dihydroxybiphenyl (23-DB), the reaction product in the same solution. Similar procedures were used to soak the 4,4Ј-dihydroxybiphenyl (44-DB), a product analog. 2,3-Dihydroxybiphenyl and 4,4Ј-dihydroxybiphenyl were from Sigma and Himedia Laboratories Pvt. Ltd., respectively. Data for these crystals were collected at a synchrotron radiation source, ESRF Grenoble, at beamline 14. All the crystals that were used for soaking experiments were grown under similar conditions as that of the apocrystals.
For all crystal structures, the diffraction data were indexed, integrated, and scaled using the HKL2000 program suite (19) . Initial phases for BphB B-356 were obtained by molecular replacement using MOLREP from the CCP4 version 6.0 software suite (20) . The crystal structure of BphB LB400 was used as a search model (Protein Data Bank (PDB) code 1BDB) (21) . Rigid body refinement was followed by iterative cycles of restrained atomic parameter refinement using the programs CNS (22) and REFMAC_5.2 (23) . The program COOT was used for analysis of electron density maps and model building (24) . The difference Fourier map for the NAD ϩ -bound form of BphB B-356 clearly showed density for the NAD ϩ at above the 3 level, allowing NAD ϩ to be modeled into the density. Solvent molecules were added where the F o Ϫ F c map had values above 3 and the 2F o Ϫ 2F c map showed a density at the 1 level.
Several cycles of rigid-body refinement and then restrained refinement were used to achieve acceptable R cryst and R free . Stereochemical properties of the models were evaluated using the program PROCHECK (25) . Figures were prepared using the program PyMOL (26) .
Docking Study-Molecular docking of all the substrates was carried out using the Schrödinger, Maestro suite, version 9.1 (Glide, version 2.6, Schrodinger, Inc., New York). The protein was prepared using the Maestro protein preparation wizard by addition of hydrogens, assigning the bond orders, and minimization of the protein using the OPLS2001 force-field until the r.m.s. deviation between the minimized structure and the starting structure reached 0.3 Å. All substrates were prepared using the Maestro Ligprep module (Ligprep, Schrodinger, Inc.). A receptor grid for docking was generated by the centroids of the selected residues, Ser-142, Tyr-155, Lys-159, Gly-150, Asn-149, and the NAD ϩ molecule. These residues and the NAD ϩ form the active site of the protein (27) . Glide was then used for docking the substrates using the Extra Precision (XP) mode. The best conformation was selected on the basis of Glide score and by visually inspecting the molecule (28) .
Whole Cell Assays to Identify Metabolites of ChlorobiphenylsMetabolites from 2,6-dichlorobiphenyl, 2,4,4Ј-trichlorobiphenyl, and 3,3Ј-dichlorobiphenyl (all 99% pure, from Ultra Scientific, Kingstown, RI) were analyzed according to a previously published protocol from suspensions of isopropyl ␤-D- 
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ternary complexes. The refined models contain two molecules per asymmetric unit for both ternary complexes.
Overall Structure-BphB B-356 exists as a tetramer made up of two asymmetric units. The tetrameric state of BphB B-356 was also confirmed by gel filtration chromatography. The two monomers in an asymmetric unit are related to each other by a noncrystallographic 2-fold axis.
As per the conventional nomenclature of SDR enzymes, the subunit contacts are named based on the three perpendicular axes P, Q, and R along the tetrameric arrangement of monomers (30) . In BphB B-356 , the monomers in an asymmetric unit coincide by the P axis. The two monomers along this axis interact through their respective ␣8 helix and ␤7 sheet as shown in The C-terminal region consists of a loop and a small helix oriented above the ␣5 and ␣6 helices of the vicinal molecule in the asymmetric unit as shown in Fig. 2B , respectively, located on helix ␣6 of the vicinal subunit. The involvement of the C termini in the subunit-subunit interaction could be of functional significance in tetrameric assembly.
Binary Complex with Coenzyme NAD ϩ -In the binary complex of the protein, both subunits in an asymmetric unit contain NAD ϩ bound at the coenzyme binding site. NAD ϩ is visible in the electron density map and is bound in a similar fashion as in other SDR family enzymes. It is placed with its adenosine ribosyl-OH group held by Asp 36 and its nicotinamide ring toward the active site of the enzyme where the nicotinamide ring lies parallel to the indole ring of Trp 90 . NAD ϩ interacts with the protein in a similar manner as in BphB LB400 (17) . Superposition of the binary structure and the apo form gives an r.m.s deviation of 0.3 Å (3559 to 3559 atoms). The structure shows a local conformational change in the C ␣ chain and side chains of some of the residues surrounding the coenzyme binding site allowing the accommodation of NAD ϩ in the cavity. These conformational changes are visible at the substrate binding loop from Met 187 to Arg 192 . As compared with the apo form, these amino acids move toward the pyrophosphate moiety and nicotinamide ring of NAD ϩ and product or product analog for about 15 min. The difference Fourier maps distinctly showed the presence of NAD ϩ in both structures and also showed bulky electron density in the active site of the complexes. 23-DB and 44-DB molecules were modeled in the available electron density at the active site for their respective complexes. The refined ternary complexes of the BphB B-356 crystal structures show that product and product analogs bind to the active site essentially in the same manner (Fig. 3, A and B) . As compared with the apo and binary forms of the enzyme, the ternary structure shows conformational changes in the residues surrounding the active site and the substrate binding loop. The distal rings of 23-DB and 44-DB were not very well defined in the electron density map and have higher B-factor than the average B-factor. To confirm the product/product analog binding to the active site, the ternary structures were refined without adding the coordinates of the product or product analog and it was observed that the ternary structure still has conformational changes. This suggests that substrates, product, or product analogs require conformational changes in the enzyme upon binding. This has also been mentioned for other enzymes that belong to the SDR family (31) (32) (33) (34) . It has been reported earlier that conformational changes occur in the substrate binding loop to shield the active site from bulk solvent, which is essential to allow hydride transfer during the catalysis (34, 35) . It could also be seen that as opposed to the BphB B-356 structure in the apo and binary forms, the active site in the ternary structure is devoid of any water molecule as shown in Fig. 4, A-C .
Superposition of C␣ atoms of the BphB B-356 -44-DB crystal structure with that of the apo-enzyme and binary structure of In the ternary complex, the complete substrate binding loop comes close to the active site and forms a compact cavity where the product/product analog binds. The same residues interact with NAD ϩ in the ternary and binary structures. However, conformational changes of residues from the substrate binding , one of the catalytic residues at the loop between ␤5 and ␣6, holds the product by formation of two hydrogen bonds with 23-DB, one with its 2-OH group (Ser-OH-23DB-2OH ϭ 3.5 Å) and the other with its 3-OH group (Ser-OH-23DB-3OH ϭ 2.1 Å). The side chain of Asn 143 makes a H-bond with the 2-OH of 23-DB (Asn 143 -ND2-23DB-2OH ϭ 2.6 Å and Asn 143 -OD1-23DB-2OH ϭ 2.5 Å). Finally, the hydroxyl group of Tyr 155 interacts with the 3-OH of 23-DB (Tyr-OH-2OH-23DB ϭ 3.2 Å).
The distal part of the ligand binding cavity is surrounded by hydrophobic residues to provide an environment suitable to accommodate the nonpolar portion of the product. These res- Fig. 5 . The position of the substrate binding loop in these two structures is similar to the opposite extremes of a arc of the swing.
As the soaking time was very short, this state could be said to have captured the structure of the substrate binding loop as an intermediate step between that of the apoenzyme and the ternary structure. The substrate binding loop was disordered in the apoenzyme and binary structure, whereas in this structure the substrate binding loop is well organized, perhaps having caught the enzyme in a process of ordering its substrate binding loop in the presence of product prior to its movement toward the active site to form a proper cavity as found in the ternary structure. The snapshots of the ligand binding loop in three different states are clearly shown in Fig. 5 . A surface view of apo, binary, ternary, and intermediate states is shown in Fig. 4 , exhibiting the differences in structure of the different enzyme forms.
Comparison of BphB B-356 with Other Enzymes in SDR FamilyStructural and sequence alignments confirm that BphB B-356 is very similar to BphB LB400 , with some variations in the active site region. Comparison of the binary structure with BphB LB400 (PDB code 1BDB) shows that most of the structural differences are observed at the N-and C-terminal regions of the protein and in the substrate binding loop region. The BphB LB400 structure is available in one form only, the binary structure complex with bound coenzyme. Its superposition with the binary structure of BphB B-356 gives an r.m.s. deviation of 0.5 Å (1666 to 1666 atoms). The relative positions of the residues that form the active site, Ser 142 , Tyr 155 , Lys 159 , Gly 150 , and Asn 143 , are similar in both molecules. The orientation of the NAD ϩ molecule in both BphB LB400 and binary BphB B-356 is almost the same.
A Blastp and Dali search for structurally related proteins against BphB B-356 shows that the closest homologous proteins belong to the SDR family (38) . Despite their low sequence identity, these proteins share very well conserved overall topology. The major difference lies in the structure of the substrate binding loop as shown in Fig. 6 . Structural alignment of these sequences shows that the substrate binding region in other pro-teins is made up of two helices joined by a small loop, unlike the elongated loop-like structure found in BphB B-356 , The one exception is the alcohol dehydrogenase from Drosophila lebanonensis (PDB code 1B15), which was not found in the Blastp or Dali search. It has been mentioned earlier that although the overall structure of SDR enzymes remains similar, their ability OCTOBER 21, 2011 • VOLUME 286 • NUMBER 42
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to metabolize a wide range of substrate is attributed to their flexible substrate binding loop (39, 40) . It could be speculated that the differences in the substrate binding loops of BphB B-356 and BphB LB400 could account for their differing specificity toward various biphenyl derivatives as substrates.
Reactivity of BphB B-356 with Polychlorinated Biphenyls-The reactivity of BphB B-356 with three different PCBs was examined. As expected from previous work with purified enzymes (12) and shown in Fig. 7 , an isopropyl ␤-D-1-thiogalactopyranosideinduced resting cell suspension of E. coli harboring pDB31 . Instead, GC-MS analysis of the metabolites produced by the co-culture showed that 3,3Ј-dichlorobiphenyl was converted to a dihydroxydichlorobiphenyl metabolite and 2,4,4Ј-trichlorobiphenyl was converted to a dihydroxy-trichlorobiphenyl. In the case of 2,6-dichlorobiphenyl, BPDO B-356 produces principally the 2Ј,3Ј-dihydro-2Ј,3Ј-dihydroxy-2,6-dichlorobiphenyl and small amounts of 3Ј,4Ј-dihydro-3Ј,4Ј-dihydroxy-2,6-dichlorobiphenyl. Based on previous observations, to obtain larger amounts of both metabolites, we have used E. coli harboring pDB31[LB400bphFG] plus pQE31[p4 bphAE]. In this case the co-culture comprised of E. coli harboring pDB31[LB400bphFG] plus pQE31[p4bphAE] plus E. coli harboring pQE31[B-356 bphB] produced two dihydroxy-2,6-dichlorobiphenyl, which shows that both the 2,3-and 3,4-dihydrodiol metabolites produced from 2,6-dichlorobiphenyl were metabolized by BphB B-356 . These results are in agreement with previous data showing that both BphB B-356 and BphB LB400 are able to catalyze the hydroxylation of 3,4-dihydro-3,4-dihydroxy-2,2Ј,5,5Ј-tetrachlorobiphenyl.
Docking of Substrates at the Active Site-To get the structural details of the substrate/product binding on the basis of the above biochemical data, the dihydrodiols of 2,4,4Ј-trichlorobiphenyl, 2,6-dichlorobiphenyl, and 3,3Ј-dichlorobiphenyl were docked at the active site of BphB B-356 . The product of BPDO, cis-(2R,3S)-dihydroxy-1-phenyl-cyclohexa-4,6-diene (BPDD), which is the substrate for BphB was first docked at the putative active site composed of the strictly conserved residues ternary structure as shown in Fig. 8A (17) . It is noteworthy that in the ternary structure and all of the docked structures of BphB B-356 , one of the hydroxyl groups of the substrate or product binds with Asn 143 , suggesting this residue could be responsible for substrate recognition.
DISCUSSION
Proposed Structural Changes during Binding of a LigandWe have determined the crystal structures in four different states: the apo-enzyme, as a binary complex with the coenzyme NAD ϩ , as a ternary complex with NAD ϩ and either product or product analog, and an intermediate state of the substrate binding loop in BphB B-356 for the first time.
The comparative crystal structure analysis of the four different forms suggests that major structural changes occur in BphB B-356 when the ligand accesses the active site in the presence of coenzyme. The most obvious changes were observed at the substrate binding region and they involved three segments of the protein as shown in Fig. 5 ) was also observed. The difference was clearly visible when the apoenzyme and binary complexes are compared with the ternary structures as shown in Fig. 5 . During the movement of helix ␣7, the hinge residue Leu 207 that causes the swing movement of the substrate binding loop also moves upwards, thus it helps in the overall displacement of the substrate binding loop toward the active site.
These observations suggest that the ligand causes major structural changes in the protein leading to the formation of a cavity for the active site. These changes could be essential for the entry and release of the substrate and product. Also it is consistent with the ordered ternary complex mechanism as proposed by Andersson et al. (34) . In the case of BphB B-356 , NAD ϩ binds first without any closure of the cavity, followed by the entry of the substrate, whereas the active site is made inaccessible for solvent during hydride transfer. Generally, in the SDR family, conformational changes in the substrate binding loop occur when the substrate binds at the active site (31) (32) (33) (34) . However, this is not always the case, for example, D-3-hydroxybutyrate dehydrogenase from Pseudomonas putida, where coenzyme binding alone is able to induce a conformational change in this loop region that is sufficient to carry out the catalytic activity (41, 42) .
In our present study Tyr 92 and Asp 190 seem to play an important role during substrate binding. These residues should be targeted in future mutagenic studies to better understand their role.
Biochemical Analysis-It was reported by Gomez-Gil et al. (12) that BPDO B-356 metabolizes 2,6-dichlorobiphenyl, 2,4,4Ј-trichlorobiphenyl, and 3,3Ј-dichlorobiphenyl to corresponding dihydrodiol metabolites more efficiently than BPDO LB400 . It is therefore interesting to examine the capacity of BphB B-356 to metabolize the dihydrodiol metabolites produced from these chlorobiphenyl congeners as they represent congeners with doubly ortho-, meta-, or para-substitution. Furthermore, to our knowledge, the ability of a 2,3-dihydro-2,3-dihydroxybiphenyl dioxygenase to catalyze the dehydrogenation of 2Ј,3Ј-dihydro-2Ј-3Ј-dihydroxy-2,4,4Ј-trichlorobiphenyl and 2Ј,3Ј-dihydro-2Ј-3Ј-dihydroxy-2,6-dichlorobiphenyl has not yet been determined. The biochemical analysis showed that 3,3Ј-dichlorobiphenyl and 2,4,4Ј-trichlorobiphenyl were transformed to dihydroxy-dichlorobiphenyl and dihydroxy-trichlorobiphenyl metabolites, respectively. In the case of 2,6-dichlorobiphenyl, BphB B-356 converts both the 2Ј,3Ј-dihydro-2Ј,3Ј-dihydroxy-2,6-dichlorobiphenyl and 3Ј,4Ј-dihydro-3Ј,4Ј-dihydroxy-2,6-dichlorobiphenyl. These biochemical observation shows that BphB B-356 is able to transform a broad range of PCBs, specifically doubly and triply substituted ortho-, meta-, and para-substituted dihydrodiols. Docking Analysis-It was observed from the biochemistry and crystal structure complexes of product and product analogs that this enzyme is able to transform a wide range of ligands. Therefore, molecular docking was carried out to examine the binding of the doubly and triply substituted chlorinated dihydrodiols. Docking analysis of the metabolites produced by BphB B-356 , which were observed by the biochemical experiments revealed that all of them may have a similar mode of binding at the active site of the BphB B-356 . The superposition of all substrates showed that they were docked at almost the same position as in 23-DB in the ternary structure as shown in Fig. 8A . The differences in binding positions were observed at the nonhydroxylated ring of different compounds, suggesting ligands may access the active site with different orientations. The docked structures of 5,6-dihydro-5,6-dihydroxy-3,3Јdichlorobiphenyl and 3Ј,4Ј-dihydro-3Ј,4Ј-dihydroxy-2,6-dichlorobiphenyl were placed in such a way that the distal rings of these compounds occupy a different space than the distal rings of the other substrates.
These variations do not seem to be associated with equivalent variations in the orientation of the hydroxylated ring. Also the surface diagram, Fig. 8B , shows that the cavity size is narrow where the hydroxylated ring binds, whereas there is a much larger volume near the nonhydroxylated ring site suitable for accommodating different compounds by orienting them differently. In combination, the biochemical data and docking experiments suggests that BphB B-356 can accommodate both ortho-meta-hydroxylated as well as meta-para-hydroxylated substrates.
